Publication:
Experimental models to study immune dysfunction in the pathogenesis of Parkinson’s disease

dc.contributor.coauthorSaponjic, Jasna
dc.contributor.coauthorMejías, Rebeca
dc.contributor.coauthorMikolovski, Neda
dc.contributor.coauthorDragic, Milorad
dc.contributor.coauthorCanak, Asuman
dc.contributor.coauthorPapoutsopoulou, Stamatia
dc.contributor.coauthorFladmark, Kari E.
dc.contributor.coauthorNtavaroukas, Panagiotis
dc.contributor.coauthorBayar Muluk, Nuray
dc.contributor.coauthorZeljkovic Jovanovic, Milica
dc.contributor.coauthorFontán-Lozano, Ángela
dc.contributor.coauthorComi, Cristoforo
dc.contributor.coauthorMarino, Franca
dc.contributor.kuauthorÖzdemir, Yasemin Gürsoy
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.date.accessioned2024-12-29T09:38:02Z
dc.date.issued2024
dc.description.abstractParkinson’s disease (PD) is a chronic, age-related, progressive multisystem disease associated with neuroinflammation and immune dysfunction. This review discusses the methodological approaches used to study the changes in central and peripheral immunity in PD, the advantages and limitations of the techniques, and their applicability to humans. Although a single animal model cannot replicate all pathological features of the human disease, neuroinflammation is present in most animal models of PD and plays a critical role in understanding the involvement of the immune system (IS) in the pathogenesis of PD. The IS and its interactions with different cell types in the central nervous system (CNS) play an important role in the pathogenesis of PD. Even though culture models do not fully reflect the complexity of disease progression, they are limited in their ability to mimic long-term effects and need validation through in vivo studies. They are an indispensable tool for understanding the interplay between the IS and the pathogenesis of this disease. Understanding the immune-mediated mechanisms may lead to potential therapeutic targets for the treatment of PD. We believe that the development of methodological guidelines for experiments with animal models and PD patients is crucial to ensure the validity and consistency of the results.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue8
dc.description.openaccessAll Open Access
dc.description.openaccessGold Open Access
dc.description.publisherscopeInternational
dc.description.volume25
dc.identifier.doi10.3390/ijms25084330
dc.identifier.eissn1422-0067
dc.identifier.issn1661-6596
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85191376334
dc.identifier.urihttps://doi.org/10.3390/ijms25084330
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22568
dc.identifier.wos1210128700001
dc.keywordsAnimal models
dc.keywordsCellular models
dc.keywordsImmune systems
dc.keywordsNeurodegeneration
dc.keywordsNeuroinflammation
dc.keywordsParkinson’s disease
dc.keywordsPeripheral immune cells
dc.languageen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.sourceInternational Journal of Molecular Sciences
dc.subjectBiochemistry and molecular biology
dc.subjectChemistry
dc.titleExperimental models to study immune dysfunction in the pathogenesis of Parkinson’s disease
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorÖzdemir, Yasemin Gürsoy

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
IR04914.pdf
Size:
1.33 MB
Format:
Adobe Portable Document Format